FR EN

Back


12/09/2017
Idinvest portfolio company, DNA Script, raises €11m in Series A Financing
DNA Script, a Paris, France-based Synthetic DNA manufacturer, raised €11m ($13m) in Series A funding. The round was led by Illumina Ventures, with participation from Merck Ventures BV, the corporate venture arm of Merck KGaA, and existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. The company intends to use the funds to strengthen its enzymatic technology and nucleotide chemistry platform in order to manufacture oligonucleotides faster and affordably.




X

X

X